The Klick Group of companies released details surrounding several significant advancements and achievements from the last nine months, including Lori Grant being named Klick Health’s Chief Executive Officer at its December 2019 Town Hall. The Klick Group also announced it is accelerating the official launches of Klick Consulting, Klick Ventures, and several new practice areas.

While Humira remains the best-selling prescription product worldwide, Keytruda has risen to the No. 2 global rank and is on track to eventually claim the top spot.

For many of us, we’re entering week 8 of Work From Home during the Covid-19 crisis. It’s been inspiring to see all those in the healthcare communications universe innovate and remain motivated to continue our critical work during these challenging times. It’s fair to say that now, more than ever, the role of effectively communicating the research, development, administration and efficacy of drug therapies is paramount to successfully navigating the world through this pandemic and beyond. We invite all families to join us virtually, for our June 18th Med Ad News Manny Awards #FamilyStyle! This year’s Manny Awards program will be designed to entertain, engage and educate our growing healthcare communications family. Set your calendars and make a night of it for the entire family to get dressed up for a virtual Black Tie event!

Scientists, researchers, health officials, regulatory agencies, governments, businesses, universities, and many others across the globe are searching for ways to defeat the coronavirus pandemic.

While the healthcare industry looks for ways to combat COVID-19, the beat goes on for drug manufacturers to continue developing and seeking marketing approval for medicines to treat many diseases and conditions. Here is a look at some of the most notable U.S. new drug approvals from Jan. 1 through April 17, 2020.

As pharma companies bolster their pipelines via multibillion-dollar acquisitions, drug manufacturers continue to heavily invest in the oncology space.

Executive management from the 2019 Manny Award agency and network winners & finalists provide expert insight on healthcare industry topics and predictions.

The Outcomes Creativity Index (OCI) represents a ranking of pharmaceutical companies and brands according to creativity and innovation. The OCI is an aggregate score-based creative achievement representing these leading U.S. and international healthcare award shows: The Outcomes LLC/Med Ad News Manny Awards; Cannes Lions; LIA: Health & Wellness; Clio Health; The One Show; The MM&M Awards; The Global Awards; and The Creative Floor Awards.

Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.

This annual compilation reviews new developments, trends and outlooks in areas such as biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biosimulation.